All Curated Mutation Sites in HPV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All

E1^E4

Keyword: Uterine Cervical Neoplasms-23451059

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	23451059	C2858G	E2	E2	Uterine Cervical Neoplasms	G R L	View
2	23451059	C3084G	E2	E2	Uterine Cervical Neoplasms	G R L	View
3	23451059	C3275G	E2	E2	Uterine Cervical Neoplasms	G R L	View
4	23451059	G2857C	E2	E2	Uterine Cervical Neoplasms	G R L	View
5	23451059	G2859T	E2	E2	Uterine Cervical Neoplasms	G R L	View
6	23451059	G3085C	E2	E2	Uterine Cervical Neoplasms	G R L	View
7	23451059	R649V	E2	E2	Uterine Cervical Neoplasms	G R L	View
8	23451059	R90A	E2	E2	Uterine Cervical Neoplasms	G R L	View
9	23451059	T2856C	E2	E2	Uterine Cervical Neoplasms	G R L	View
10	23451059	V15L	E2	E2	Uterine Cervical Neoplasms	G R L	View
11	23451059	L648C	E1	E1	Uterine Cervical Neoplasms	G R L	View
12	23451059	T2856G	E1	E1	Uterine Cervical Neoplasms	G R L	View
13	23451059	C4915T	L2	L2	Uterine Cervical Neoplasms	G R L	View
14	23451059	C5147A	L2	L2	Uterine Cervical Neoplasms	G R L	View
15	23451059	C5701G	L1	L1	Uterine Cervical Neoplasms	G R L	View
16	23451059	C6460G	L1	L1	Uterine Cervical Neoplasms	G R L	View
17	23451059	C6625G	L1	L1	Uterine Cervical Neoplasms	G R L	View
18	23451059	C6842G	L1	L1	Uterine Cervical Neoplasms	G R L	View
19	23451059	D493N	L1	L1	Uterine Cervical Neoplasms	G R L	View
20	23451059	G5503A	L1	L1	Uterine Cervical Neoplasms	G R L	View
21	23451059	G6906A	L1	L1	Uterine Cervical Neoplasms	G R L	View
22	23451059	P344R	L1	L1	Uterine Cervical Neoplasms	G R L	View
23	23451059	P399R	L1	L1	Uterine Cervical Neoplasms	G R L	View
24	23451059	P471R	L1	L1	Uterine Cervical Neoplasms	G R L	View
25	23451059	P91R	L1	L1	Uterine Cervical Neoplasms	G R L	View
26	23451059	R25Q	L1	L1	Uterine Cervical Neoplasms	G R L	View
27	23451059	A864G	E7	E7	Uterine Cervical Neoplasms	G R L	View
28	23451059	C640T	E7	E7	Uterine Cervical Neoplasms	G R L	View
29	23451059	N92S	E7	E7	Uterine Cervical Neoplasms	G R L	View
30	23451059	A551C	E6	E6	Uterine Cervical Neoplasms	G R L	View
31	23451059	C287G	E6	E6	Uterine Cervical Neoplasms	G R L	View
32	23451059	C14A	E2	E2	Uterine Cervical Neoplasms	G R L	View

Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.